A supported self-management approach to gout has been developed which incorporates self-testing of urate levels and a smartphone application that will prompt participants to self-test and allow clinical researchers to titrate urate lowering therapies. This study evaluates whether the approach to gout is able to achieve target levels of serum urate, and better control of gout flares.
The feasibility of this approach will be evaluated in patients with gout referred to secondary care.
| Study Type : |
Interventional (Clinical Trial) |
| Estimated Enrollment : |
56 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Intervention Model Description: |
Participants will be randomised in a ratio of 2:1 to either supported self management or usual care. |
| Masking: |
Single (Outcomes Assessor) |
| Masking Description: |
Laboratory staff measuring biochemical traits will be blind to treatment allocation. |
| Primary Purpose: |
Treatment |
| Official Title: |
Gout Self-Monitoring Aiming to Reach Target Serum Urate (Gout-SMART): Feasibility Study of Supported Self-management of Gout in Secondary Care Patients Requiring Escalation of Urate Lowering Therapy |
| Anticipated Study Start Date : |
January 2018 |
| Estimated Primary Completion Date : |
December 2019 |
| Estimated Study Completion Date : |
June 2020 |
For enrollment please visit
www.clinicaltrials.gov.
